{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T07:13:14Z","timestamp":1760425994874,"version":"3.40.5"},"reference-count":39,"publisher":"Cambridge University Press (CUP)","issue":"1","license":[{"start":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T00:00:00Z","timestamp":1631145600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Acta Neuropsychiatr."],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Smoking is highly prevalent in the psychiatric population, and hospital admittance usually results in partial or complete smoking cessation. Tobacco use is known to affect the metabolism of certain psychoactive drugs, but whether smoking influences the plasma concentration of tricyclic antidepressants (TCAs) remains unclear. This article investigates the possible effect of smoking on the plasma concentration of TCAs. A systematic review of the literature available on PubMed and EMBASE as of October 2020 was carried out using PRISMA guidelines. Studies reporting plasma concentrations of any TCA in both a smoking and a non-smoking group were included and compared. Ten eligible studies were identified and included. In the eight studies investigating the effect of smoking on amitriptyline and\/or nortriptyline, five studies found no significant effect. Two studies investigating the effect of smoking on imipramine found a significant effect, and one study investigating the effect of smoking on doxepin found no significant effect. The majority of studies included in this review were influenced by small study populations and other methodical issues. The effect of smoking on the plasma concentration of TCAs is still not entirely clear. There is a possibility that smoking affects the distribution of TCA metabolites, but this is probably not of clinical importance.<\/jats:p>","DOI":"10.1017\/neu.2021.28","type":"journal-article","created":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T08:25:08Z","timestamp":1631175908000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":4,"title":["The effect of smoking on the plasma concentration of tricyclic antidepressants: a systematic review"],"prefix":"10.1017","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2539-6948","authenticated-orcid":false,"given":"Nicklas Hasselblad","family":"Lundstr\u00f8m","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4616-5188","authenticated-orcid":false,"given":"Nikolaj K.","family":"Holgersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maija Bruun","family":"Haastrup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2021,9,9]]},"reference":[{"key":"S0924270821000284_ref8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1055\/s-0043-116492","article-title":"Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017","volume":"51","author":"Hiemke","year":"2018","journal-title":"Pharmacopsychiatry"},{"key":"S0924270821000284_ref37","unstructured":"World Health Organization - Regional Office for Europe (2019) Tobacco Use: Trends Report 2019. Available at Euro.who.int, (accesseded 05 November 2020)."},{"key":"S0924270821000284_ref24","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-198609000-00007"},{"key":"S0924270821000284_ref20","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1977214453"},{"key":"S0924270821000284_ref25","doi-asserted-by":"publisher","DOI":"10.1016\/S0278-5846(01)00304-9"},{"key":"S0924270821000284_ref26","doi-asserted-by":"publisher","DOI":"10.1007\/BF00427486"},{"key":"S0924270821000284_ref38","doi-asserted-by":"publisher","DOI":"10.2165\/11318030-000000000-00000"},{"key":"S0924270821000284_ref29","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(96)00180-1"},{"key":"S0924270821000284_ref23","first-page":"16","article-title":"Pharmacodynamics of imipramine in depressed patients","volume":"11","author":"Perel","year":"1975","journal-title":"Psychopharmacology Bulletin"},{"key":"S0924270821000284_ref2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.4.5686.764"},{"key":"S0924270821000284_ref18","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1176\/ajp.138.6.841","article-title":"Effect of alcohol consumption and cigarette smoking on antidepressant levels of depressed patients","volume":"138","author":"Linnoila","year":"1981","journal-title":"The American Journal of Psychiatry"},{"key":"S0924270821000284_ref34","unstructured":"Thorn, CF (n.d.) Amitriptyline and Nortriptyline Pathway, Pharmacokinetics. PharmGkb. The Pharmacogenomics Knowledgebase . Available at http:\/\/www.pharmgkb.org\/pathway\/PA166163647, 30 November 2020."},{"key":"S0924270821000284_ref6","first-page":"399","article-title":"Plasma level monitoring of antidepressants: theoretical basis and clinical application","volume":"39","author":"Gram","year":"1984","journal-title":"Advances in Biochemical Psychopharmacology"},{"key":"S0924270821000284_ref11","doi-asserted-by":"publisher","DOI":"10.1023\/A:1016478708902"},{"key":"S0924270821000284_ref28","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0000000000000250"},{"key":"S0924270821000284_ref15","doi-asserted-by":"publisher","DOI":"10.1016\/0895-4356(95)00020-5"},{"key":"S0924270821000284_ref30","first-page":"359","article-title":"Clinical pharmacology of antidepressant drugs: pharmacogenetics","volume":"39","author":"Sj\u00f6qvist","year":"1984","journal-title":"Advances in Biochemical Psychopharmacology"},{"key":"S0924270821000284_ref5","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/34.5.863"},{"key":"S0924270821000284_ref27","doi-asserted-by":"publisher","DOI":"10.1023\/A:1006949816036"},{"key":"S0924270821000284_ref22","first-page":"n71","article-title":"The PRISMA, 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"S0924270821000284_ref21","doi-asserted-by":"publisher","DOI":"10.1159\/000139533"},{"key":"S0924270821000284_ref4","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2011.70"},{"volume-title":"The Maudsley Prescribing Guidelines in Psychiatry","year":"2018","author":"Taylor","key":"S0924270821000284_ref33"},{"key":"S0924270821000284_ref9","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.9.1643"},{"key":"S0924270821000284_ref35","doi-asserted-by":"publisher","DOI":"10.1007\/s00406-006-0663-5"},{"key":"S0924270821000284_ref31","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198802000-00009"},{"key":"S0924270821000284_ref17","doi-asserted-by":"publisher","DOI":"10.1001\/jama.284.20.2606"},{"volume-title":"Tricyclic Antidepressants. I StatPearls","year":"2021","author":"Moraczewski","key":"S0924270821000284_ref19"},{"key":"S0924270821000284_ref12","doi-asserted-by":"publisher","DOI":"10.1007\/BF00431822"},{"key":"S0924270821000284_ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-006-0209-9"},{"key":"S0924270821000284_ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-014-1676-z"},{"key":"S0924270821000284_ref13","doi-asserted-by":"publisher","DOI":"10.1097\/01.fpc.0000167331.30905.9e"},{"key":"S0924270821000284_ref32","first-page":"131","article-title":"Estimation of cytochrome P-450 CYP1A2 activity in 863 healthy Caucasians using a saliva-based caffeine test","volume":"9","author":"Tantcheva-Po\u00f3r","year":"1999","journal-title":"Pharmacogenetics"},{"key":"S0924270821000284_ref16","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp060414"},{"key":"S0924270821000284_ref3","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200115060-00005"},{"volume-title":"Essential Medical Statistics","year":"2010","author":"Kirkwood","key":"S0924270821000284_ref14"},{"key":"S0924270821000284_ref36","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-012-0952-2"},{"key":"S0924270821000284_ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1980.tb02025.x"},{"key":"S0924270821000284_ref39","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1977.03280210059023"}],"container-title":["Acta Neuropsychiatrica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0924270821000284","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,10]],"date-time":"2022-02-10T10:00:20Z","timestamp":1644487220000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0924270821000284\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,9]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S0924270821000284"],"URL":"https:\/\/doi.org\/10.1017\/neu.2021.28","relation":{},"ISSN":["0924-2708","1601-5215"],"issn-type":[{"type":"print","value":"0924-2708"},{"type":"electronic","value":"1601-5215"}],"subject":[],"published":{"date-parts":[[2021,9,9]]},"assertion":[{"value":"\u00a9 The Author(s), 2021. Published by Cambridge University Press on behalf of Scandinavian College of Neuropsychopharmacology","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}}]}}